$CORZ

DUCHENE TODD M sold $263K of CORZ

DUCHENE TODD M (See remarks) sold 10,000 shares of Core Scientific, Inc./tx (CORZ) at $26.25 ($0.26M total) on 2026-05-26 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DUCHENE TODD M
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CORZ
Neutral
medium confidence
Mentioned
$CORZ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CORZNeutralLow
01

Why it matters

The newest fact is the specific sale: 10,000 shares at $26.2540 on 2026-05-26, with holdings after transaction of 2,088,895 shares, executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may briefly reassess sentiment around insider activity, but there is no accompanying fundamental catalyst in the text.

03

What to watch

The filing does not state motives, and 10b5-1 plans can be executed regardless of outlook; without additional disclosures, the signal is weak.

Relevance 3/10Novelty 3/10Timing: filed 2026-05-28, sale dated 2026-05-26

Background

This is an SEC Form 4 insider transaction disclosure for Core Scientific, Inc. (CORZ).

Company-level read

Ticker impact

$CORZNeutralMedium confidence
Context

Form 4 shows officer Todd M Duchene sold 10,000 Core Scientific shares at $26.2540 on 2026-05-26 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and should fade unless follow-on selling appears.

Evidence & confidence

The article discloses only an open-market sale size and price, explicitly tied to a pre-arranged 10b5-1 plan, with no new company-specific news (guidance, contracts, litigation, or restructuring).

Market effects

Minimal; insider sale does not change sector fundamentals or credit/liquidity assumptions on its own.

None indicated.

None indicated.

Counterpoint

A large insider sale can still coincide with private information, even if labeled 10b5-1, so traders may watch for clustering of similar sales.

Key entities

  • Core Scientific, Inc.

    Subject of the Form 4 insider transaction disclosure (CORZ).

  • DUCHENE TODD M

    Officer who executed the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CRWVMed

CoreWeave, AI landlord stocks sink to lowest levels in more than a year as the price of insuring CoreWeave's debt doubles

Neocloud stocks, including CoreWeave (CRWV), IREN, Core Scientific (CORZ), and Cipher Mining (CIFR), have fallen over 40% since July. CoreWeave's credit default swap costs have doubled, signaling increased default risk. Microsoft (MSFT) has gained nearly as much. Nebius (NBIS) is an exception, performing better due to lower debt. Elon Musk noted lenders are restricting funding for AI data center-dependent companies.

$BTC-USDMed

AI Pivot Fails to Slow Bitcoin Mining Competition as Hashrate Surges

Bitcoin's network hashrate hit a seven-month high of 1 zettahash per second, despite large miners shifting to AI. Mining difficulty rose 5.92% in October, with another 5.16% increase expected. Public miners' hashrate fell 23% while AI revenue rose 52% in Q2 2026, displacing about $1.5 billion in equipment. Companies like Core Scientific and IREN reduced Bitcoin production, while MARA and Riot absorbed displaced network share.

$APLDMed

Applied Digital Sinks 4% as Rotation Out of Debt-Funded AI Builders Extends; TeraWulf Dips 3%, Core Scientific Retreats 2%

Applied Digital (APLD) shares fell 4% to $19.59, extending a downturn in leveraged AI data center developers. TeraWulf (WULF) and Core Scientific (CORZ) also declined. JPMorgan cut APLD's bond rating to Neutral, citing debt concerns. APLD reported strong Q1 revenue growth but carries significant debt. Management maintains confidence in its balance sheet and funding plans.

$CORZHigh

KBW keeps Core Scientific at outperform, says AMD’s 1.9 GW reservation is overlooked

KBW reiterated its Outperform rating and $28 price target on Core Scientific (CORZ), citing overlooked 1.9 GW of AMD reservation capacity. The firm values existing leases at $15.54 per share, with a blended NOI/EV yield of 8.3%. KBW attended Core Scientific's investor day and noted AMD's option for additional capacity. CORZ closed at $15.43 on Tuesday, implying 81.5% upside to the target.